Cargando…

T cell landscape within primary melanoma as a biomarker of survival after cancer vaccination in patients with metastatic disease

Detalles Bibliográficos
Autores principales: Vasaturo, Angela, Halilovic, Altuna, Bol, Kalijn, Verweij, Dagmar, Blokx, Willeke, Groenen, Patricia, van Krieken, Han, Textor, Johannes, de Vries, Jolanda, Figdor, Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652495/
http://dx.doi.org/10.1186/2051-1426-3-S2-P420
_version_ 1782401766365593600
author Vasaturo, Angela
Halilovic, Altuna
Bol, Kalijn
Verweij, Dagmar
Blokx, Willeke
Groenen, Patricia
van Krieken, Han
Textor, Johannes
de Vries, Jolanda
Figdor, Carl
author_facet Vasaturo, Angela
Halilovic, Altuna
Bol, Kalijn
Verweij, Dagmar
Blokx, Willeke
Groenen, Patricia
van Krieken, Han
Textor, Johannes
de Vries, Jolanda
Figdor, Carl
author_sort Vasaturo, Angela
collection PubMed
description
format Online
Article
Text
id pubmed-4652495
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46524952015-11-25 T cell landscape within primary melanoma as a biomarker of survival after cancer vaccination in patients with metastatic disease Vasaturo, Angela Halilovic, Altuna Bol, Kalijn Verweij, Dagmar Blokx, Willeke Groenen, Patricia van Krieken, Han Textor, Johannes de Vries, Jolanda Figdor, Carl J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652495/ http://dx.doi.org/10.1186/2051-1426-3-S2-P420 Text en Copyright © 2015 Vasaturo et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Vasaturo, Angela
Halilovic, Altuna
Bol, Kalijn
Verweij, Dagmar
Blokx, Willeke
Groenen, Patricia
van Krieken, Han
Textor, Johannes
de Vries, Jolanda
Figdor, Carl
T cell landscape within primary melanoma as a biomarker of survival after cancer vaccination in patients with metastatic disease
title T cell landscape within primary melanoma as a biomarker of survival after cancer vaccination in patients with metastatic disease
title_full T cell landscape within primary melanoma as a biomarker of survival after cancer vaccination in patients with metastatic disease
title_fullStr T cell landscape within primary melanoma as a biomarker of survival after cancer vaccination in patients with metastatic disease
title_full_unstemmed T cell landscape within primary melanoma as a biomarker of survival after cancer vaccination in patients with metastatic disease
title_short T cell landscape within primary melanoma as a biomarker of survival after cancer vaccination in patients with metastatic disease
title_sort t cell landscape within primary melanoma as a biomarker of survival after cancer vaccination in patients with metastatic disease
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652495/
http://dx.doi.org/10.1186/2051-1426-3-S2-P420
work_keys_str_mv AT vasaturoangela tcelllandscapewithinprimarymelanomaasabiomarkerofsurvivalaftercancervaccinationinpatientswithmetastaticdisease
AT halilovicaltuna tcelllandscapewithinprimarymelanomaasabiomarkerofsurvivalaftercancervaccinationinpatientswithmetastaticdisease
AT bolkalijn tcelllandscapewithinprimarymelanomaasabiomarkerofsurvivalaftercancervaccinationinpatientswithmetastaticdisease
AT verweijdagmar tcelllandscapewithinprimarymelanomaasabiomarkerofsurvivalaftercancervaccinationinpatientswithmetastaticdisease
AT blokxwilleke tcelllandscapewithinprimarymelanomaasabiomarkerofsurvivalaftercancervaccinationinpatientswithmetastaticdisease
AT groenenpatricia tcelllandscapewithinprimarymelanomaasabiomarkerofsurvivalaftercancervaccinationinpatientswithmetastaticdisease
AT vankriekenhan tcelllandscapewithinprimarymelanomaasabiomarkerofsurvivalaftercancervaccinationinpatientswithmetastaticdisease
AT textorjohannes tcelllandscapewithinprimarymelanomaasabiomarkerofsurvivalaftercancervaccinationinpatientswithmetastaticdisease
AT devriesjolanda tcelllandscapewithinprimarymelanomaasabiomarkerofsurvivalaftercancervaccinationinpatientswithmetastaticdisease
AT figdorcarl tcelllandscapewithinprimarymelanomaasabiomarkerofsurvivalaftercancervaccinationinpatientswithmetastaticdisease